Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXXXXXXX KOMISE X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2021/849

ze xxx 11. března 2021,

xxxxxx xx xxx xxxxx xxxxxxxxxxxx technickému a vědeckému xxxxxxx xxxx xxxx 3 xxxxxxx XX xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx x&xxxx;xxxxx

(Xxxx s významem xxx EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,

x&xxxx;xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 xx dne 16. prosince 2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx a směsí, o změně x&xxxx;xxxxxxx xxxxxxx 67/548/EHS x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx xx xx.&xxxx;37 odst. 5 xxxxxxxxx xxxxxxxx,

xxxxxxxx k těmto xxxxxxx:

(1)

Xxxxxxx 3 v části 3 přílohy XX xxxxxxxx (ES) č. 1272/2008 xxxxxxxx seznam xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxxxxx xxxxx xx xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx I uvedeného xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx xxx chemické xxxxx (xxxx xxx „xxxxxxxx“) byly x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (ES) x.&xxxx;1272/2008 předloženy xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx některých xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx harmonizovaných xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx xxxxx. Poté, xx Xxxxx xxx xxxxxxxxxx xxxxx (RAC) xxxxxxxx zohlednil xxxxxxxxxx xxxxxxxxxxxx xxxxx, přijal x&xxxx;xxxxx návrhům stanoviska (2). Xxxxxxx xxxxxxxxxx xxxxxx XXX xxxx:

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 pro 1,2,4-xxxxxxx,

xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx 1,4-xxxxxx,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx benzyl-salicylát,

stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxx (XXX),

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxx (ISO),

stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxxx faktory xxx xxxxxxxxxxx xxxxxxxxxxxx xxx xxxxx prostředí x&xxxx;xxxxx xxxxxxxxxxxx měď uvedených x&xxxx;xxxxxxxx Xxxxxx (XX) 2016/1179,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx X-{2-[[1,1’-xx(xxxxxxxxxxx)]-2-xx]xxxxx}-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxx,

xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 pro X-xxxxxxx-X-[1-xxxxxx-2-(2,4,6-xxxxxxxxxxxxx)xxxxx]-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxxxx,

xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx x-xxxxx; 1-xxxxxxxxx-4-xxxxxxxxxxxx,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx x-xxxxxx-1,3-xxxx; α-xxxxxxxx; 1-xxxxxxxxx-4-xxxxxxxxxxxxxxx-1,3-xxxx,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxxxx,

xxxxxxxxxx ze dne 15.&xxxx;xxxxxx&xxxx;2019 xxx (X)-x-xxxxxx-1,8-xxxx, x-xxxxxxx,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx thiofanát-methyl,

stanovisko xx dne 15. března 2019 xxx xxxxxxxxx-xxxxxx (XXX), X-(2,6-xxxxxxx-x-xxxxx) O,O-dimethylthiofosfát,

stanovisko xx xxx 15. března 2019 pro xxxxxxxxxx,

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxx xxxxxxxx,

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 pro azamethifos,

stanovisko xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 2-xxxxxxxxxxx-1-xx,

xxxxxxxxxx xx xxx 13. června 2019 pro 2,2-xxxxxx-2-xxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 3-xxxxxxxxxxx-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx,

xxxxxxxxxx xx dne 13. června 2019 xxx 6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx;

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxxxx (XXX), X-(2,4-xxxxxxxxxxxx)-2-[3-(xxxxxxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx;

xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxx (XXX), 1-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxx,

xxxxxxxxxx ze xxx 13.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxx,

xxxxxxxxxx xx dne 13. června 2019 xxx X-xxxxxxxxxx xxxxxxxx,

xxxxxxxxxx xx xxx 13. června 2019 xxx xxxxxxxx(2,6-xxxxxxxxxxxxx)-x-xxxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 20. září 2019 xxx 1,2-xxxxx-4-xxxxxxxxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx 4-methylpentan-2-on,

stanovisko xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx xxxxxxx; xxxx boritý; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; tetraboritan xxxxxxx, bezvodý; xxxxxx xxx xxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; xxxxxxxxxxxx disodný, xxxxxxxxxxx,

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx kyselinu xxxxxxxxxx,

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx,

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 pro xxxxxxxxxx,

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx dimethomorf,

stanovisko xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxx xxxxxxx,

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxxx (XXX); [(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxxxxxx-xxxxxx (XXX),

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx-X (XXX); (X)-2-(4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

xxxxxxxxxx xx xxx 20. září 2019 xxx xxxxxx-xxxxxxxxx,

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 pro xxxxxxxxxx (XXX),

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 pro xxxxxxxxxxxxxxx (XXX),

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx tritikonazol,

stanovisko xx dne 5.&xxxx;xxxxxxxx&xxxx;2019 xxx 1,4-xxxxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro 3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-xxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro 3-xxxxxxxxxxxxx,

xxxxxxxxxx ze dne 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxxx (XXX); xxxxxx-X- (xxxxxxxxxxxx-2-xx)xxxxxxxx,

xxxxxxxxxx xx xxx 5. prosince 2019 xxx xxxxxxxxxxxx cis/trans +/- 40/60; (RS)-α-kyan-3-fenoxybenzyl (1XX,3XX;1XX,3XX)-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

xxxxxxxxxx ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxx (XXX); (XX)-2-(4-xxxxxxxxx-4-xxxxxx-5-xxx-4,5-xxxxxxxxxxxxxxx-2-xx)-5-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx,

xxxxxxxxxx xx dne 5.&xxxx;xxxxxxxx&xxxx;2019 xxx tetrafluorethylen,

stanovisko xx xxx 5. prosince 2019 pro xxxxxxxxxxxx (XXX); X-xxxxx-{3-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-5-xxxxxx-1,3,5-xxxxxxxxxxx-4-xxxxxx}xxxx,

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxx-xxxxx (XXX); xxxxx-4-[xxxxxxxxxxx(xxxxxxx)xxxxxxxx]-3,5-xxxxxxxxxxxxxxxxxxxxxxxxx.

(3)

Xxxxxx xxxxxx toxicity (XXX) xx xxxxxxxxx xxxxxxx xx xxxxxxxxx xxxxxxxxxxx xxxxxx toxicity x&xxxx;xxxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxxxxx jako xxxxx xxxxxxxxxx akutní xxxxxxxx. Xxxxxxxxx xxxxxxxxxxxxxxx hodnot XXX do xxxxxxx xxxxxxxxx x&xxxx;xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxx harmonizaci xxxxxxxxxxx xxxxx a poskytuje xxxxxxx xxxxxxx pověřeným xxxxxxxxxxxx. Xx xxxxxxx dalších xxxxxxxxx posouzení některých xxxxx agentura stanovila xxxxxxx XXX pro xxxx měďný, xxxxxxx-xxxxxxxxxxx xxxxxxxxx, hexahydroxid-síran xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx xxxxxx, xxxxxx xxxxxx (potažené xxxxxxxxxxx xxxxxxxxx), uhličitan xxxxxxx – hydroxid xxxxxxx (1:1) x&xxxx;xxxxxxxx xxxxxxx; xxxxxxxx xxxxxxx, xxxxxxxxxxxx jíchu; xxxxxxx xxxxxxxx síranu xxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx x&xxxx;xxxxx xxxxxxx, xxxxxxxxxxx, kromě xxxxxxxx navrhovaných xx xxxxxxxxxxxx výboru RAC xxx jiné xxxxx. Xxxxxxx hodnoty XXX xx měly být xxxxxxxx xx xxxxxxxxxxxxxx xxxxxxx tabulky 3 x&xxxx;xxxxx 3 přílohy XX xxxxxxxx (XX) x.&xxxx;1272/2008.

(4)

Xxxxxx xxxxxxxx dodatečné xxxxxxxxx, které zpochybnily xxxxxxx posouzení xxxxxxx xx stanoviscích XXX xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxxxxxxxxx se mankozebu, xx dne 20.&xxxx;xxxx&xxxx;2019 xxxxxxxx xx 4-methyl-2-pentanonu x&xxxx;xx xxx 20.&xxxx;xxxx&xxxx;2019 xxxxxxxx xx xxxxxxxxxxxx. Xxxxxx xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx xx xx xxxxxxxxxx k tomu, xxx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx xx xxxxxxxxxxxx XXX.

(5)

Xxxxxx xxxxx xxxxxxxx za xxxxxx xxxxxx, aktualizovat xx xxxxxx harmonizovanou klasifikaci x&xxxx;xxxxxxxxxx určitých xxxxx.

(6)

Xxxxxxxx (XX) č. 1272/2008 xx xxxxx xxxx být xxxxxxxxxxxxx způsobem xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx nebo aktualizovaných xxxxxxxxxxxxxxx xxxxxxxxxxx xx xxxxxx být, x&xxxx;xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxx xxxxx, jelikož xxxxxxxxxx xxxxxxxxx určitou xxxx xx to, xxx xxxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí xxxxx xxxx revidovaným xxxxxxxxxxxx a prodali xxxxxxxxx xxxxxx. Xxxx xxxx xx xxxxxx nezbytná x&xxxx;xxxx, xxx xxxxxxxxxx xxxx xxxxxxxx času xxxxxxxx xxxxxxxx xxxxx x&xxxx;xxxxxxxxx xxxxxxxx dodržování xxxxxxx xxxxxxxx xxxxxxxxx, xxxxx vznikají x&xxxx;xxxxxxxx xxxx provedených xxxxx xxxxxx xxxxxxxx. Tyto xxxxxxxxx mohou xxxxxxxxx xxxxxxxxx xxxxxxxxx v čl. 22 xxxx.&xxxx;1 xxxx. x) xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1907/2006&xxxx;(3) xxxx xxxxxxxxx stanovené x&xxxx;xxxxxx&xxxx;50 nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (EU) x.&xxxx;528/2012&xxxx;(4). Xxxxxxxxxxx by xxxx xxxx xxx xxxxxxxx xxxxxxxx nové xxxx aktualizované xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx označování x&xxxx;xxxxxx xx xxxxxxxxxxx xxxxxxx xxxx xxxxx použitelnosti xxxxxx xxxxxxxx x&xxxx;xxx xxx jeho xxxxxx x&xxxx;xxxxxxxx, aby byla xxxxxxxxx xxxxxx úroveň xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx xxxxxxxxx x&xxxx;xxx xx dodavatelům xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Článek 1

Změny nařízení (XX) x.&xxxx;1272/2008

Xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx VI xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx v souladu x&xxxx;xxxxxxxx xxxxxx xxxxxxxx.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

Toto xxxxxxxx xxxxxxxx v platnost xxxxxxxx dnem po xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx se xxx xxx 17.&xxxx;xxxxxxxx 2022.

Xxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx článku xxxxx být xxxxx x&xxxx;xxxxx klasifikovány, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx s tímto xxxxxxxxx ode dne xxxx vstupu v platnost.

Toto xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx použitelné xx xxxxx xxxxxxxxx státech.

V Bruselu xxx 11. března 2021.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX DER XXXXX


(1)&xxxx;&xxxx;Xx. xxxx. L 353, 31.12.2008, s. 1.

(2)  Stanoviska xxxx xxxxxxxx xx xxxx xxxxxxxxxxx stránce: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 1907/2006 ze xxx 18.&xxxx;xxxxxxxx&xxxx;2006x&xxxx;xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, x&xxxx;xxxxxxx Evropské xxxxxxxx xxx chemické xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX a o zrušení nařízení Xxxx (XXX) č. 793/93, xxxxxxxx Komise (ES) x.&xxxx;1488/94, směrnice Xxxx 76/769/XXX a směrnic Xxxxxx 91/155/XXX, 93/67/XXX, 93/105/ES x&xxxx;2000/21/XX (Xx. xxxx. X&xxxx;396, 30.12.2006, s. 1).

(4)  Nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;528/2012 ze xxx 22.&xxxx;xxxxxx&xxxx;2012x&xxxx;xxxxxxxx biocidních xxxxxxxxx xx xxx x&xxxx;xxxxxx používání(Úř. věst. X&xxxx;167, 27.6.2012, s. 1).


XXXXXXX

X&xxxx;xxxxxxx VI nařízení (XX) x.&xxxx;1272/2008 xx xxxxxxx 3 x&xxxx;xxxxx 3 mění xxxxx:

1)

Xxxxxxxx xx tyto xxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx ES

Číslo XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx faktory x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx symbolů x&xxxx;xxxxxxxxxx xxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx doplň. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„601-093-00-6

1,4-xxxxxxxxxxxxxxxx

209-335-9

571-58-4

Xxxxx Xxx. 4

Xxx. Xxx. 1

Eye Xxxxx. 2

Aquatic Xxxxx 1

Xxxxxxx Chronic 3

H302

H304

H319

H400

H412

GHS07

GHS08

GHS09

Dgr

H302

H304

H319

H410

orální: XXX&xxxx;= 1 300  mg/kg XX

X&xxxx;= 1“

„601-094-00-1

1-xxxxxxxxx-4-xxxxxxxxxxxx;

x-xxxxx

202-796-7

99-87-6

Xxxx. Liq. 3

Xxxxx Xxx. 3

Xxx. Xxx. 1

Xxxxxxx Chronic 2

X226

X331

X304

X411

XXX02

XXX06

XXX08

XXX09

Xxx

X226

X331

X304

X411

xxxxxxxxx: XXX&xxxx;= 3 mg/l (xxxx)“

„601-095-00-7

x-xxxxxx-1,3-xxxx; 1-xxxxxxxxx-4-xxxxxxxxxxxxxxx-1,3-xxxx

α-xxxxxxxx

202-795-1

99-86-5

Xxxx. Liq. 3

Xxxxx Tox. 4

Xxxx Xxxx. 1

Asp. Xxx. 1

Xxxxxxx Xxxxxxx 2

X226

X302

X317

X304

X411

XXX02

XXX07

XXX08

XXX09

Xxx

X226

X302

X317

X304

X411

xxxxxx: XXX&xxxx;= 1 680  mg/kg XX“

„602-110-00-X

xxxxxxxxxxxxxxxxx

204-126-9

116-14-3

Xxxx. 1X

X350

XXX08

Xxx

X350“

„604-095-00-5

6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx;

[XXXX]

204-327-1

119-47-1

Xxxx. 1B

H360F

GHS08

Dgr

H360F“

„606-152-00-X

(5-chlor-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanon; xxxxxxxxxx

-

688046-61-9

Xxxx. 2

Aquatic Chronic 1

X351

X410

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 1“

„607-747-00-7

2,2-xxxxxx-2-xxxxxxxxxxxxx; [XXXXX]

233-539-7

10222-01-2

Xxxxx Xxx. 2

Xxxxx Xxx. 3

XXXX XX 1

Skin Xxxxx. 2

Eye Dam. 1

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Aquatic Xxxxxxx 1

X330

X301

X372 (dýchací xxxxx) (xxxxxxxxx)

X315

X318

X317

X400

X410

XXX06

XXX08

XXX05

XXX09

Xxx

X330

X301

X372 (xxxxxxx xxxxx) (xxxxxxxxx)

X315

X318

X317

X410

xxxxxxxxx: XXX&xxxx;= 0,24&xxxx;xx/x (xxxxx xxxx mlha)

orální: XXX&xxxx;= 118&xxxx;xx/xx XX

X&xxxx;= 1

X&xxxx;= 1“

„607-748-00-2

[X-(X,X)]-5-(-1-xxxxxxx-2,6,6-xxxxxxxxx-4-xxxxxxxxxxx-2-xx-1-xx)-3-xxxxxxxxxxx-2,4-xxxxxxx xxxxxxxx;

X-xxxxxxxxx xxxxxxxx

244-319-5

21293-29-8

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 1

X&xxxx;= 1“

„607-749-00-8

xxxxxx-xxxxxxxxx

204-317-7

119-36-8

Xxxx. 2

Xxxxx Tox. 4

Xxxx Xxxx. 1X

Xxxxxxx Xxxxxxx 3

X361x

X302

X317

X412

XXX07

XXX08

Xxx

X361x

X302

X317

X412

xxxxxx: XXX&xxxx;= 890&xxxx;xx/xx XX“

„607-750-00-3

xxxxxxxxx xxxxxxxx

201-069-1

77-92-9

Xxx Xxxxx. 2

XXXX XX 3

X319

X335

XXX07

Xxx

X319

X335“

„607-751-00-9

xxxxxxxxxxxxxxx-xxxxxx (XXX);

xxxxxx-2-({[4-xxxxxx-6-(xxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)xxxxxxx

-

97780-06-8

Xxx Irrit. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X319

X400

X410

XXX07

XXX09

Xxx

X319

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100“

„607-752-00-4

xxxxxxxxxx-xxxxx (ISO);

ethyl-4-[cyklopropyl(hydroxy)methylen]-3,5-dioxocyklohexankarboxylát

-

95266-40-3

STOT RE 2

Xxxx Xxxx. 1X

Xxxxxxx Xxxxxxx 1

X373 (xxxxxxxxxxxxxxxxxx xxxxx)

X317

X410

XXX08

XXX07

XXX09

Xxx

X373 (xxxxxxxxxxxxxxxxxx xxxxx)

X317

X410

X&xxxx;= 1“

„607-753-00-X

(3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-epibrassinolid

-

78821-43-9

Aquatic Xxxxxxx 4

X413

X413“

„607-754-00-5

xxxxxx-xxxxxxxxx

204-262-9

118-58-1

Xxxx Xxxx. 1B

H317

GHS07

Wng

H317“

„607-755-00-0

(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl-methyl-karbonát;

tolpyralát

-

1101132-67-5

Carc. 2

Xxxx. 2

XXXX XX 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361fd

H373 (oči)

H400

H410

GHS08

GHS09

Wng

H351

H361fd

H373 (xxx)

X410

X&xxxx;= 10

M = 100“

„613-337-00-9

xxxxxxxxxxxxxx (XXX);

2-[2-(1-xxxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxx)-2-xxxxxxxxxxxxx]-2,4-xxxxxxx-3X-1,2,4-xxxxxxx-3-xxxxx

-

178928-70-6

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 10

M = 1“

„613-338-00-4

xxxxxxxxxxx (ISO); X-[(6-xxxxx-2-xxxxxxxxxx[4,5-x]xxxxxxx-3(2X)-xx)xxxxxx]-(X,X-xxxxxxxx)xxxxxxxxxx

252-626-0

35575-96-3

Xxxx. 2

Xxxxx Tox. 3

Xxxxx Xxx. 4

XXXX SE 1

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X331

X302

X370 (xxxxxxx xxxxxx)

X317

X400

X410

XXX06

XXX08

XXX09

Xxx

X351

X331

X302

X370 (xxxxxxx systém)

H317

H410

inhalační: XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000

X&xxxx;= 1&xxxx;000 “

„613-339-00-X

3-xxxxxxxxxxxxx

215-925-7

1453-58-3

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxxx Xxxx. 1

Eye Xxx. 1

X360X

X302

X373 (plíce)

H314

H318

GHS08

GHS07

GHS05

Dgr

H360D

H302

H373 (xxxxx)

X314

xxxxxx: XXX&xxxx;= 500 mg/kg XX“

„613-340-00-5

xxxxxxxx (XXX); 2-(2-chlorbenzyl)-4,4-dimethyl-1,2-oxazolidin-3-on

-

81777-89-1

Acute Tox. 4

Xxxxx Xxx. 4

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X302

X400

X410

XXX07

XXX09

Xxx

X332

X302

X410

xxxxxxxxx: XXX&xxxx;= 4,85&xxxx;xx/x (xxxxx xxxx mlha)

orální: XXX&xxxx;= 768&xxxx;xx/xx XX

X&xxxx;= 1

X&xxxx;= 1“

„614-030-00-2

xxxxxxxxx-xxxxxxx (XXX); (4“X)-4“-xxxxx-4“-(xxxxxxxxxxx)xxxxxxxxxx X1-xxxxxxx

-

155569-91-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Xxxxx Xxx. 3

XXXX SE 1

XXXX RE 1

Eye Xxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X331

X311

X301

X370 (xxxxxxx xxxxxx)

X372 (nervový xxxxxx)

X318

X400

X410

XXX06

XXX05

XXX08

XXX09

Xxx

X331

X311

X301

X370 (nervový systém)

H372 (xxxxxxx xxxxxx)

X318

X410

xxxxxxxxx:

XXX&xxxx;= 0,663

xx/x (xxxxx xxxx mlha)

dermální:

ATE = 300

xx/xx TH

orální: ATE =

60&xxxx;xx/xx XX

XXXX XX 1; X372: X&xxxx;≥&xxxx;5&xxxx;%; XXXX RE 2; X373: 0,5 % ≤ X&xxxx;&xx;&xxxx;5&xxxx;%

X&xxxx;= 10 000

M = 10&xxxx;000 “

„616-234-00-7

X-xxxxxxx-X-[1-xxxxxx-2-(2,4,6-xxxxxxxxxxxxx)-xxxxx]-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxxxx

-

1228284-64-7

Xxxx. 2

Repr. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X361x

X400

X410

XXX08

XXX09

Xxx

X351

X361x

X410

X&xxxx;= 1

X&xxxx;= 1“

„616-235-00-2

X-{2-[[1,1’-xx(xxxxxxxxxxx)]-2-xx]xxxxx}-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxx

-

874967-67-6

Xxxx. 2

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 2

X351

X400

X411

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 1“

2)

xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 005-007-00-2; 005-008-00-8; 005-011-00-4; 005-011-01-1; 005-011-02-9; 006-069-00-3; 006-076-00-1; 015-113-00-0; 028-007-00-4; 029-002-00-X; 029-015-00-0; 029-016-00-6; 029-017-00-1; 029-018-00-7; 029-019-01-X; 029-020-00-8; 029-021-00-3; 029-022-00-9; 029-023-00-4; 601-029-00-7; 601-096-00-2; 603-024-00-5; 603-066-00-4; 603-098-00-9; 606-004-00-4; 607-421-00-4; 607-424-00-0; 607-434-00-5; 608-058-00-4; 612-067-00-9; 612-252-00-4; 613-048-00-8; 613-102-00-0; 613-111-00-X; 613-166-00-X; 613-208-00-7; 613-267-00-9; 613-282-00-0; 616-032-00-9; 616-106-00-0 x&xxxx;616-113-00-9 xx nahrazují xxxxxx položkami:

Indexové číslo

Chemický xxxxx

Xxxxx XX

Xxxxx CAS

Klasifikace

Označení

Specifické xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx nebezpečnosti

Kódy xxxxxxxxxxxx xxx o nebezpečnosti

Kódy výstražných xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„005-007-00-2

xxxxxxxx boritá [1]

xxxxxxxx xxxxxx [2]

233-139-2 [1]

234-343-4 [2]

10043-35-3 [1]

11113-50-1 [2]

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„005-008-00-8

xxxx xxxxxx

215-125-8

1303-86-2

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„005-011-00-4

xxxxxxxxxxxx xxxxxxx, monohydrát; [1]

tetraboritan xxxxxxx, bezvodý; [2]

sodná xxx kyseliny xxxxxxxxxxx [3]

xxxxxxxxxxxx xxxxxxx, dekahydrát [4]

xxxxxxxxxxxx disodný pentahydrát [5]

235-541-3 [1]

215-540-4 [2]

237-560-2 [3]

215-540-4 [4]

215-540-4 [5]

12267-73-1 [1]

1330-43-4 [2]

13840-56-7 [3]

1303-96-4 [4]

12179-04-3 [5]

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„006-069-00-3

xxxxxxxxx-xxxxxx (XXX);

xxxxxxxx (1,2-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxxxx;

xxxxxxxx 4,4′-(o-fenylen)bis(3-thioallofanát)

245-740-7

23564-05-8

Carc. 2

Xxxx. 2

Xxxxx Tox. 4

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Aquatic Chronic 1

X351

X341

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X341

X332

X317

X410

xxxxxxxxx: XXX&xxxx;= 1,7&xxxx;xx/x

(xxxxx xxxx xxxx)

X&xxxx;= 10

M = 10“

„006-076-00-1

xxxxxxxx (XXX); X,X’-xxxxxxxxxx(xxxxxxxxxxxxxx) xxxxxxxxx, xxxxxxxxx xxxxxxx xx zinečnatou solí

-

8018-01-7

Carc. 2

Xxxx. 1B

STOT RE 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X360X

X373 (xxxxxx xxxxx, xxxxxxx xxxxxx)

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X360X

X373 (xxxxxx xxxxx, xxxxxxx xxxxxx)

X317

X410

X&xxxx;= 10

X&xxxx;= 10“

„015-113-00-0

xxxxxxxxx-xxxxxx (XXX);

X-(2,6-xxxxxxx-x-xxxxx) X,X-xxxxxxxxxxxxxxxxxx

260-515-3

57018-04-9

Xxxx Sens. 1X

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1

M = 1“

„028-007-00-4

xxxxxxxx xxxxxxxx;

xxxxxxxxx nikelnatý; [1]

xxxxxxxxxxxx [2]

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Xxxx. 1&xxxx;X

Xxxx. 2

Xxxxx Tox. 3

XXXX XX 1

Skin Sens. 1

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X350x

X341

X331

X372**

X317

X400

X410

XXX08

XXX06

XXX09

Xxx

X350x

X341

X331

X372**

X317

X410

xxxxxxxxx:

XXX&xxxx;= 0,92 mg/l

(prach xxxx mlha)“

„029-002-00-X

oxid xxxxx

215-270-7

1317-39-1

Xxxxx Xxx. 4

Xxxxx Xxx. 4

Xxx Dam. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X332

X302

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X332

X302

X318

X410

xxxxxxxxx: XXX&xxxx;= 3,34&xxxx;xx/x (xxxxx nebo mlha)

orální: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 100

X&xxxx;= 10“

„029-015-00-0

thiokyanatan xxxxx

214-183-1

1111-67-7

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

XXX032

X&xxxx;= 10

X&xxxx;= 10“

„029-016-00-6

xxxx xxxxxxx

215-269-1

1317-38-0

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 100

X&xxxx;= 10“

„029-017-00-1

xxxxxxx-xxxxxxxxxxx xxxxxxxxx

215-572-9

1332-65-6

Xxxxx Xxx. 4

Xxxxx Xxx. 3

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X301

X400

X410

XXX06

XXX09

Xxx

X332

X301

X410

xxxxxxxxx: XXX&xxxx;= 2,83&xxxx;xx/x (xxxxx xxxx mlha)

orální: XXX&xxxx;= 299&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„029-018-00-7

hexahydroxid-síran xxxxxxxxxxxx; [1]

xxxxxxxxxxxx-xxxxx tetraměďnatý hydrát [2]

215-582-3 [1]

215-582-3 [2]

1333-22-8 [1]

12527-76-3 [2]

Acute Xxx. 4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X302

X400

X410

XXX07

XXX09

Xxx

X302

X410

xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx TH

M = 10

X&xxxx;= 10“

„029-019-01-X

xxxxxx xxxxxx (xxxxxxxx xxxxxxxxxxx xxxxxxxxx)

-

-

Xxxxx Xxx. 3

Xxxxx Xxx. 4

Eye Xxxxx. 2

Aquatic Acute 1

Xxxxxxx Xxxxxxx 1

H331

H302

H319

H400

H410

GHS06

GHS09

Dgr

H331

H302

H319

H410

inhalační: XXX&xxxx;= 0,733 mg/l (xxxxx xxxx mlha)

orální: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

M = 10“

„029-020-00-8

xxxxxxxxx xxxxxxx – xxxxxxxx xxxxxxx (1:1)

235-113-6

12069-69-1

Acute Xxx. 4

Xxxxx Xxx. 4

Xxx Irrit. 2

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X302

X319

X400

X410

XXX07

XXX09

Xxx

X332

X302

X319

X410

xxxxxxxxx: XXX&xxxx;= 1,2 mg/l (xxxxx xxxx xxxx)

xxxxxx: XXX&xxxx;= 500 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„029-021-00-3

hydroxid xxxxxxx

243-815-9

20427-59-2

Xxxxx Xxx. 2

Xxxxx Xxx. 4

Xxx Xxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X330

X302

X318

X400

X410

XXX06

XXX05

XXX09

Xxx

X330

X302

X318

X410

xxxxxxxxx: XXX&xxxx;= 0,47&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx: XXX&xxxx;= 500 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„029-022-00-9

xxxxxxxxxxx jícha;

reakční xxxxxxxx xxxxxx xxxxxxxxx x&xxxx;xxxxxxxxx vápenatého

-

8011-63-0

Acute Xxx. 4

Xxx Xxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X332

X318

X410

xxxxxxxxx: XXX&xxxx;= 1,97 mg/l (xxxxx nebo mlha)

M = 10

X&xxxx;= 1“

„029-023-00-4

xxxxx xxxxxxx, xxxxxxxxxxx

231-847-6

7758-99-8

Xxxxx Xxx. 4

Xxx Xxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H302

H318

H410

orální: XXX&xxxx;= 481&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 1“

„601-029-00-7

xxxxxxxx;

xxxxxxx [1]

(S)-p-mentha-1,8-dien; x-xxxxxxx [2]

trans-1-methyl-4-(1-methylvinyl)cyklohexen; [3]

(±)-1-xxxxxx-4-(1-xxxxxxxxxxx)xxxxxxxxxx [4]

205-341-0 [1]

227-815-6 [2]

229-977-3 [3]

231-732-0 [4]

138-86-3 [1]

5989-54-8 [2]

6876-12-6 [3]

7705-14-8 [4]

Flam. Xxx. 3

Xxxx Xxxxx. 2

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X226

X315

X317

X400

X410

XXX02

XXX07

XXX09

Xxx

X226

X315

X317

X410

X“

„601-096-00-2

(X)-x-xxxxxx-1,8-xxxx;

x-xxxxxxx

227-813-5

5989-27-5

Xxxx. Xxx. 3

Xxxx Xxxxx. 2

Xxxx Xxxx. 1X

Xxx. Tox. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 3

X226

X315

X317

X304

X400

X412

XXX02

XXX07

XXX08

XXX09

Xxx

X226

X315

X317

X304

X410

X&xxxx;= 1“

„603-024-00-5

1,4-xxxxxx

204-661-8

123-91-1

Xxxx. Liq. 2

Xxxx. 1X

XXXX XX 3

Xxx Xxxxx. 2

X225

X350

X335

X319

XXX02

XXX08

XXX07

Xxx

X225

X350

X335

X319

XXX019

XXX066

X“

„603-066-00-4

7-xxx-3-xxxxxxxxxxxxxxx[4.1.0]xxxxxx; 1,2-xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx 4-xxxxxxxxxxxxxxxxxxxxxxx

203-437-7

106-87-6

Xxxx. 1X

Xxxx. 2

Xxxx. 1B

Acute Xxx. 3

Xxxxx Xxx. 4

X350

X341

X360X

X331

X302

XXX08

XXX06

Xxx

X350

X341

X360X

X331

X302

xxxxxxxxx: XXX&xxxx;= 0,5 mg/l (xxxxx xxxx xxxx)

xxxx: XXX&xxxx;= 1&xxxx;847 &xxxx;xx/xx XX“

„603-098-00-9

2-xxxxxxxxxxx-1-xx

204-589-7

122-99-6

Xxxxx Xxx. 4

STOT XX 3

Xxx Xxx. 1

H302

H335

H318

GHS05

GHS07

Dgr

H302

H335

H318

orální:

ATE = 1&xxxx;394 &xxxx;xx/xx XX“

„606-004-00-4

4-xxxxxxxxxxxx-2-xx; xxxxxxxx(xxxxxx)xxxxx

203-550-1

108-10-1

Xxxx. Xxx. 2

Xxxx. 2

Xxxxx Tox. 4

STOT XX 3

Xxx Xxxxx. 2

X225

X351

X332

X336

X319

XXX02

XXX07

XXX08

Xxx

X225

X351

X332

X336

X319

XXX066

xxxxxxxxx: XXX&xxxx;= 11 mg/l (xxxx)“

„607-421-00-4

xxxxxxxxxxxx (ISO);

α-kyan-3-fenoxybenzyl 3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropankarboxylát; xxxxxxxxxxxx xxx/xxxxx +/- 40/60

257-842-9

52315-07-8

Xxxxx Xxx. 4

Acute Xxx. 4

STOT XX 3

XXXX RE 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X302

X335

X373 (xxxxxxx xxxxxx)

X400

X410

XXX07

XXX08

XXX09

Xxx

X332

X302

X335

X373 (xxxxxxx xxxxxx)

X410

xxxxxx; XXX&xxxx;= 500&xxxx;xx/xx XX

xxxxxxxxx; ATE = 3,3&xxxx;xx/x (prach xxxx xxxx)

X&xxxx;= 100000

X&xxxx;= 100000“

„607-424-00-0

trifloxystrobin (XXX); xxxxxx-(X)-α-(xxxxxxxxxxxx)-2-{[(X)-({1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx}xxxxx)xxx]xxxxxx}xxxxxx-1-xxxxxx

-

141517-21-7

Xxxx.

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X317

X400

X410

XXX07

XXX09

Xxx

X362

X317

X410

X&xxxx;= 100

X&xxxx;= 10“

„607-434-00-5

xxxxxxxx-X (XXX) [1] x&xxxx;xxxx xxxx;

(X)-2-(4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxx xxxxxxxx [1] x&xxxx;xxxx xxxx

240-539-0 [1]

16484-77-8 [1]

Xxxxx Xxx. 4

Xxx Xxx. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X302

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X302

X318

X410

xxxxxx: ATE = 431 mg/kg XX

X&xxxx;= 10

M = 10“

„608-058-00-4

xxxxxxxxxxxx (XXX);

[(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx

-

66230-04-4

Xxxxx Xxx. 3

Acute Xxx. 3

STOT SE 1

XXXX XX 2

Xxxx Xxxx. 1

Aquatic Acute 1

Xxxxxxx Chronic 1

X331

X301

X370 (xxxxxxx xxxxxx)

X373

X317

X400

X410

XXX06

XXX08

XXX09

Xxx

X331

X301

X370 (xxxxxxx xxxxxx)

X373

X317

X410

xxxxxx; ATE = 88,5 mg/kg XX

xxxxxxxxx; XXX&xxxx;= 0,53 mg/l (xxxxx nebo xxxx)

X&xxxx;= 10&xxxx;000

X&xxxx;= 10&xxxx;000 “

„612-067-00-9

3-(xxxxxxxxxxx)-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx

220-666-8

2855-13-2

Xxxxx Xxx. 4

Xxxx Corr. 1X

Xxx Xxx. 1

Skin Xxxx. 1&xxxx;X

X302

X314

X318

X317

XXX05

XXX07

Xxx

X302

X314

X317

xxxxxx: XXX&xxxx;= 1&xxxx;030 &xxxx;xx/xx TH

Skin Xxxx. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„612-252-00-4

xxxxxxxxxxxx (XXX);

(X)-1-(6-xxxxx-3-xxxxxxxxxxxxx)-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxxx;

(2X)-1-[(6-xxxxxxxxxxxx-3-xx) methyl]-N-nitroimidazolidin-2-imin

428-040-8

138261-41-3

Acute Xxx. 3

Aquatic Acute 1

Xxxxxxx Xxxxxxx 1

X301

X400

X410

XXX06

XXX09

Xxx

X301

X410

xxxxxx: XXX&xxxx;= 131&xxxx;xx/xx XX

X&xxxx;= 100

X&xxxx;= 1&xxxx;000 “

„613-048-00-8

karbendazim (XXX); xxxxxx-X- (xxxxxxxxxxxx-2-xx)xxxxxxxx

234-232-0

10605-21-7

Xxxx. 1X

Xxxx. 1X

Xxxx Xxxx. 1

Xxxxxxx Acute 1

Aquatic Xxxxxxx 1

H340

H360FD

H317

H400

H410

GHS07

GHS08

GHS09

Dgr

H340

H360FD

H317

H410

M = 10

M = 10“

„613-102-00-0

xxxxxxxxxxx (XXX); (X,X)-4-(3-(4-xxxxxxxxxx)-3-(3,4-xxxxxxxxxxxxxx)xxxxxxxx)xxxxxxxx

404-200-2

110488-70-5

Xxxx. 1X

Xxxxxxx Xxxxxxx 2

X360X

X411

XXX08

XXX09

Xxx

X360X

X411“

„613-111-00-X

1,2,4-xxxxxxx

206-022-9

288-88-0

Xxxx. 1X

Xxxxx Xxx. 4

Eye Xxxxx. 2

H360FD

H302

H319

GHS08

GHS07

Dgr

H360FD

H302

H319

orální: XXX&xxxx;= 1&xxxx;320  mg/kg TH“

„613-166-00-X

flumioxazin (XXX);

7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx

-

103361-09-7

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 1&xxxx;000 “

„613-208-00-7

imazamox (XXX);

(XX)-2-(4-xxxxxxxxx-4-xxxxxx-5-xxx-4,5-xxxxxxxxxxxxxxx-2-xx)-5-(xxxxxxxxxxxxx)xxxxxxxxxx xxxxxxxx

-

114311-32-9

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 10

M = 10“

„613-267-00-9

xxxxxxxxxxxx (XXX);

X-xxxxx-{3-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-5-xxxxxx-1,3,5-xxxxxxxxxxx-4-xxxxxx}xxxx

428-650-4

153719-23-4

Xxxx. 2

Xxxxx Tox. 4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361xx

X302

X400

X410

XXX07

XXX08

XXX09

Xxx

X361xx

X302

X410

xxxxxx: XXX&xxxx;= 780&xxxx;xx/xx XX

X&xxxx;= 10

M = 10“

„613-282-00-0

xxxxxxxxxxxx (XXX);

(1XX)-5-[(X)-4-xxxxxxxxxxxxxxx]-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx

-

138182-18-0

Xxxx. 2

STOT XX 2

Aquatic Xxxxx 1

Xxxxxxx Chronic 1

X361x

X373

X400

X410

XXX08

XXX09

Xxx

X361x

X373

X410

X&xxxx;= 1

X&xxxx;= 1“

„616-032-00-9

xxxxxxxxxxxx (XXX);

X-(2,4-xxxxxxxxxxxx)-2-[3-(xxxxxxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx; 2′,4′-xxxxxxx-2-(α,α,α-xxxxxxxx-x-xxxxxxxx)xxxxxxxxxxxxx

-

83164-33-4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 10&xxxx;000

X&xxxx;= 1&xxxx;000 “

„616-106-00-0

xxxxxxxxxx (ISO); xxxxxx-X-(3-{[X-(3-(xxxxxxxxxxx)xxxxxxxxx]xxx}xxxxx)xxxxxxxx

237-199-0

13684-63-4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

X&xxxx;= 10

X&xxxx;= 10“

„616-113-00-9

xxxxxxxxxxx (XXX);

xxxxx-X-{3-[(X-xxxxxxxxxxxxxx)xxx]xxxxx}xxxxxxxx

237-198-5

13684-56-5

Xxxx. 2

Aquatic Xxxxx 1

Aquatic Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 10

X&xxxx;= 10“

3)

xxxxxxx xxxxxxxxxxxx indexovému xxxxx 015-192-00-1 xx xxxxxxx.